Department of Clinical and Chemical Pathology, Medical Research Division, National Research Center, Al-Bohouth Street, Cairo, 12311, Egypt.
Cardiovasc Diabetol. 2018 Jul 4;17(1):97. doi: 10.1186/s12933-018-0742-8.
The aim of the present study was to examine the association of angiopoietin-like proteins-8 (ANGPTL8) rs2278426, cholesteryl ester-transfer protein (CETP) rs708272 and endothelial nitric oxide synthase (NOS3) rs1799983 variants with type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD), and to investigate the effect of the potential interaction between these variants on disease risk.
Our study included 272 subjects classified into 68 patients with T2DM, 68 patients with T2DM complicated with CVD and 136 control subjects. ANGPTL8 c194C>T, CETP Taq1B and NOS3 G894T polymorphisms were genotyped using TaqMan SNP Genotyping Assay.
The presence of NOS3, ANGPTL8, and homozygous CETP B1 variants were associated with increased risk of T2DM by 3.07-, 2.33- and 1.75-fold, respectively. NOS3 variant was associated with 3.08-fold increased risk of CVD (95% CI 1.70-5.60), while ANGPTL8 C allele was associated with 2.8-fold increased risk of CVD in T2DM patients (95% CI 1.13-6.97). Concomitant presence of both, CETP B1 and NOS3 T allele, associated with increased risk of T2DM, CVD and CVD in T2DM by 8.36-, 6.33- and 7.87-fold, respectively, while concomitant presence of ANGPTL8 variant with either CETP B1 or NOS3 T allele was not associated with increased risk of T2DM or CVD. However, concomitant presence of the three variants together elevated the risk of T2DM by 13.22-fold (p = 0.004), CVD risk by 8.86-fold (p = 0.03) and highly elevated the risk of CVD in T2DM patients by 13.8-fold (p = 0.008).
Concomitant presence of CETP B1, NOS3 T and ANGPTL8 T alleles augments the risk of CVD and T2DM. Further studies to clarify the mechanism of gene-gene interaction in the pathogenesis of CVD and T2DM are needed.
本研究旨在探讨血管生成素样蛋白 8(ANGPTL8)rs2278426、胆固醇酯转移蛋白(CETP)rs708272 和内皮型一氧化氮合酶(NOS3)rs1799983 变异与 2 型糖尿病(T2DM)和心血管疾病(CVD)的关联,并探讨这些变异之间潜在相互作用对疾病风险的影响。
我们的研究纳入了 272 名受试者,分为 68 名 T2DM 患者、68 名 T2DM 合并 CVD 患者和 136 名对照。使用 TaqMan SNP 基因分型分析检测 ANGPTL8 c194C>T、CETP Taq1B 和 NOS3 G894T 多态性。
NOS3、ANGPTL8 和纯合 CETP B1 变异的存在使 T2DM 的风险分别增加了 3.07 倍、2.33 倍和 1.75 倍。NOS3 变异与 CVD 的 3.08 倍风险相关(95%CI 1.70-5.60),而 ANGPTL8 C 等位基因与 T2DM 患者的 2.8 倍 CVD 风险相关(95%CI 1.13-6.97)。同时存在 CETP B1 和 NOS3 T 等位基因使 T2DM、CVD 和 T2DM 合并 CVD 的风险分别增加了 8.36 倍、6.33 倍和 7.87 倍,而同时存在 ANGPTL8 变异与 CETP B1 或 NOS3 T 等位基因与 T2DM 或 CVD 风险增加无关。然而,同时存在这三种变异使 T2DM 的风险增加了 13.22 倍(p=0.004),CVD 风险增加了 8.86 倍(p=0.03),T2DM 患者 CVD 风险增加了 13.8 倍(p=0.008)。
同时存在 CETP B1、NOS3 T 和 ANGPTL8 T 等位基因会增加 CVD 和 T2DM 的风险。需要进一步研究以阐明 CVD 和 T2DM 发病机制中基因-基因相互作用的机制。